IP Library Patent Application 12468668
Patent Application
App. No. 12/468,668

ADJUVANT ENHANCED ABLATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/468,668
Filed
May 19, 2009
Art Unit
3767
USPC
604/20
Abstract

An adjuvant applicator comprises a balloon coupled to a distal end of a tube. The balloon has an inflated state and a deflated state. The exterior surface of the balloon includes a coating of an adjuvant. In one embodiment, the adjuvant is configured to absorb energy from laser light. In a method, the adjuvant applicator is provided. The balloon is inserted into the patient adjacent target tissue. The coating of adjuvant is then applied to the target tissue using the adjuvant applicator by inflating the balloon to the inflated state, which places the adjuvant in contact with the target tissue. Next, the balloon is removed from the patient and the adjuvant coated tissue is exposed to laser light. In one embodiment, the exposure of the adjuvant coated tissue to the laser light ablates the target tissue.

Claims (41)

1 - 5 . (canceled)

6 . A method of treating a condition of a patient comprising:

providing an adjuvant applicator comprising:

tubing;

a balloon coupled to the distal end of the tubing and having an inflated state and a deflated state, which are reached through the passage of gas or liquid through the tubing; and

a coating of an adjuvant on an exterior surface of the balloon;

inserting the balloon in the deflated state in the patient adjacent target tissue of the patient;

applying the coating of adjuvant to the target tissue using the adjuvant applicator comprising:

inflating the balloon to an inflated state wherein the inflated state expands the exterior surface of the balloon such that the adjuvant contacts the target tissue; and

removing the balloon from the patient; and

exposing the adjuvant coated target tissue to the laser light;

ablating the target tissue responsive to exposing the adjuvant coated target tissue to the laser light.

7 . The method of claim 6 , wherein the adjuvant is suspended in a gel.

8 . (canceled)

9 . The method of claim 6 , wherein applying a coating of adjuvant to the target tissue comprises maintaining the balloon in the inflated stated for a predetermined period of time prior to deflating the balloon, wherein a portion of the adjuvant remains adhered to the target tissue.

10 . The method of claim 6 , wherein applying a coating of adjuvant to target tissue comprises deflating the balloon prior to removing the balloon from the patient.

11 . The method of claim 6 , wherein exposing the adjuvant coated target tissue to the laser light comprises exposing the adjuvant coated target tissue to laser light having a wavelength of approximately 532 nm.

12 . The method of claim 6 , wherein the target tissue is selected from the group consisting of the uterus, the colon, the rectum, the prostate, the vagina, the cervix, the urethra, the bladder, the anus, the intestines and the esophagus.

13 . The method of claim 6 , wherein inserting the balloon in the deflated state in the patient adjacent target tissue, comprises inserting the balloon in the deflated state in the uterus of the patient, wherein the target tissue comprises the uterine wall.

14 . The method of claim 13 , wherein inflating the balloon to the inflated state creates a seal between the uterus and the cervix of the patient.

15 . A kit comprising:

an adjuvant applicator comprising:

tubing; and

a balloon coupled to the distal end of the tubing and having an inflated state and a deflated state, which are reached through the passage of gas through the tubing;

an adjuvant; and

a package containing the adjuvant applicator and the adjuvant.

16 . The kit of claim 15 , further comprising instructions for using the adjuvant applicator.

17 . The kit of claim 15 , wherein the adjuvant is configured to absorb energy from laser light having a wavelength of approximately 532 nm.

18 . A method of treating a condition of a female patient comprising:

providing an adjuvant applicator comprising:

tubing;

a balloon coupled to the distal end of the tubing and having an inflated state and a deflated state, which are reached through the passage of gas or liquid through the tubing; and

a coating of an adjuvant on an exterior surface of the balloon;

inserting the balloon in the deflated state in the uterus of the patient;

applying the coating of adjuvant to the uterine wall of the patient using the adjuvant applicator comprising:

inflating the balloon to an inflated state wherein the inflated state expands the exterior surface of the balloon such that the adjuvant contacts the uterine wall; and

removing the balloon from the patient; and

exposing the adjuvant coated uterine wall to laser light;

ablating tissue of the uterine wall responsive to exposing the adjuvant coated target tissue to the laser light.

19 . The method of claim 18 , wherein the tissue of the uterine wall comprises the endometrium of the uterine wall.

20 . The method of claim 18 , wherein the tissue of the uterine wall comprises fibroids.

Assignments (3)
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2009
From: FRIGSTAD, JOHN R.
To: AMS RESEARCH CORPORATION
Reel/Frame 022749/0887 →